Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
First Claim
1. A transdermal therapeutic system comprisingat least one matrix layer having an active ingredient phase comprising one or more sex steroids and, in an amount of 1 to 40% by weight relative to the entire active ingredient phase, dimethyl isosorbide, anda skin contact adhesive,provided that 3-keto-desogestrel is not one of the sex steroids and provided that the system does not contain an active ingredient-containing, non-free-flowing gel phase.
2 Assignments
0 Petitions
Accused Products
Abstract
Transdermal therapeutic systems that contain sex steroids and optionally penetration-enhancers and crystallization inhibitors are described, which are characterized in that they contain dimethyl isosorbide, with the exception of systems that contain active ingredient-containing, non-free-flowing gel phases or 3-keto-desogestrel.
127 Citations
20 Claims
-
1. A transdermal therapeutic system comprising
at least one matrix layer having an active ingredient phase comprising one or more sex steroids and, in an amount of 1 to 40% by weight relative to the entire active ingredient phase, dimethyl isosorbide, and a skin contact adhesive, provided that 3-keto-desogestrel is not one of the sex steroids and provided that the system does not contain an active ingredient-containing, non-free-flowing gel phase.
Specification